Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Q&A

Date

11 Sep 2022

Session

GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Topics

Tumour Site

Endometrial Cancer;  Colon and Rectal Cancer

Presenters

Andrea Cercek

Authors

I.L. Ray-Coquard1, A. Leary2, A. Cercek3

Author affiliations

  • 1 Medical Oncology Department, Centre Léon Bérard, 69008 - Lyon/FR
  • 2 Medicine Dept., Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR
  • 3 Medicine Department, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, 10065 - New York/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.